Methotrexat Ebewe

Methotrexate, the active ingredient in Methotrexat Ebewe, is an antimetabolite (folate antagonist) presented as an intravenous solution for injection use. It is employed to treat autoimmune diseases such as rheumatoid arthritis and psoriasis, as well as certain cancers including acute lymphoblastic leukemia, non‑Hodgkin lymphoma and breast cancer.

GNH USA supplies Methotrexat Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Methotrexate is used in several disease categories where inhibition of folate metabolism is therapeutic.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell proliferation and improves lesions. - Acute lymphoblastic leukemia: induces remission by targeting rapidly dividing leukemic cells. - Non‑Hodgkin lymphoma: provides cytotoxic activity against malignant lymphocytes. - Breast cancer: used as part of combination chemotherapy regimens to inhibit tumor growth.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: general tiredness. - Mouth sores: ulceration of oral mucosa. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Severe liver toxicity: risk of fibrosis or cirrhosis. - Pulmonary toxicity: interstitial pneumonitis. - Myelosuppression: severe neutropenia or pancytopenia.

When prescribing methotrexate, several safety considerations are required.

- Pregnancy contraindication: drug is teratogenic; avoid in pregnancy (Category X). - Breastfeeding avoidance: contraindicated during lactation. - Renal function monitoring: assess creatinine clearance before and during therapy. - Hepatic function monitoring: regular liver enzyme tests required. - Hematologic monitoring: complete blood count should be checked regularly. - Store at ambient temperature: keep below 25°C, protect from light and moisture, retain in original packaging.

Methotrexate interacts with several medicines that may alter its efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Proton pump inhibitors: may raise serum methotrexate levels. - Penicillins (e.g., ampicillin): reduce renal clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Sulfonamides: can displace methotrexate from plasma proteins. - Trimethoprim‑sulfamethoxazole: additive bone marrow suppression. - Live vaccines: risk of infection due to immunosuppression.